Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Why CytoMed GDTC might be the portfolio Builder you need In Focus 20260508 How Roboai Warr AIIOW guidance shapes future expectations AIIOW Q4 Earnings Roboai Warr Reports No Financial Data ASIC Ategrity Specialty Insurance Company Holdings reports robust Q4 2025 earnings with 299 percent EPS beat and 234 percent annual revenue growth Is it too late to buy Illumination ILLUU stock today Earnings Report Palo Alto Networks PANW Fundamental Strength Supports Wall Street Bullish Consensus Amid Peers Underperformance Public Storage PSA PreQ1 2026 Earnings Preview Wall Street Consensus Metrics and NearTerm Outlook Is Old ONBPO stock forming a continuation pattern Institutional Demand 20260420 Corporate Earnings Show Strength in Q4 But Forward Momentum Under Scrutiny Editorial Indias Gautam Adani Settles Civil Suit with US SEC Key Implications Target Bets on Viral Toys to Revive Sales Momentum Chimera 2029 CIMO Flat at 2530 Consolidation Continues 20260518 Aclarion WT ACONW Trading at 004 Key Decision Point 20260518 CoDiag CODX Surges 4380 Nearing 207 Resistance 20260519 Inflation Pressure Broadens Beyond Oil and Iran Consumers Face Rising Costs in Housing Food and Services IIT Madras and IIT Kanpur to Support CBSE in Resolving Revaluation Portal Technical Issues AlphaSense Highlights 10 Major Mergers and Acquisitions Shaping 2025 Paul Tudor Jones Boosts IREN Stake by 57 in Bet on AI Infrastructure Buildout US Advocacy Groups Urge Investigation Into Roblox Over Child Safety and Spending Concerns Wall Street Edges Higher as Healthcare and Tech Lead Dow Outperforms SCZM Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher MT Bank Q1 2026 Earnings EPS Beats Estimates by 2 as Shares Edge Higher PTCT Q1 2026 Earnings Significant EPS Beat Highlights Cost Discipline Amid Pipeline Progress OC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response RNGR Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher on Resilient Operations Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines WISeKey WKEY Surges Over 6 as Support Holds and Momentum Builds Rani Therapeutics RANI Plunges Nearly 10 as Stock Tests Critical Support Level New Fortress Energy NFE Surges 5 as Stock Tests Key Resistance Near 066 New Germany Fund GF Gains 22 as Price Approaches Key Resistance Workiva WK Edges Lower Amid Sector Pressure Key Levels in Focus